Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC) — ENGAGE

Spastic Hemiparesis Clinical Trial

Official title:
An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis

Status Completed

Clinical Trial Summary

The purpose of this clinical study is to assess whether AbobotulinumtoxinA (Dysport®) injections in upper and lower limbs accompanied with a personal exercise plan called "Guided Self-rehabilitation Contract" (GSC) can improve voluntary movements in subjects with hemiparesis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02969356
Study type	Interventional
Source	Ipsen
Contact
Status	Completed
Phase	Phase 4
Start date	December 18, 2016
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05436366` - Soleus Loading Response During Walking	N/A
Completed	`NCT05546190` - A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
Completed	`NCT03549975` - Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study	Phase 4
Active, not recruiting	`NCT06001736` - Utility of CC7 Transfer in Stroke Subtypes	N/A
Recruiting	`NCT02944929` - The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke	Phase 3
Recruiting	`NCT03402854` - tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy	N/A